126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500
| CAS 号 | 126602-89-9 |
| 分子式 | C53H67N9O10S C34H50N4O9S |
| 分子量 | N/A g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
本产品为药物标准品(126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500,CAS 126602-89-9),分子式 C53H67N9O10S C34H50N4O9S。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。
本品适用于HPLC、GC、LC-MS/MS、GC-MS等主要色谱平台的定量分析,可作为外标法校准标准品或系统适用性测试参考物质使用。 CAS编号 126602-89-9 对应的化合物(英文标识 126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)me
应用场景:(126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-
| 中文名称 | |
| 分子式 | C53H67N9O10S C34H50N4O9S |
| 分子量 | 1713.08 g/mol |
| 外观形态 | 淡黄色至黄色无定形粉末。(含硫化合物特征性气味) |
| 纯度 | 97%+ |
| 储存条件 | 阴凉处(≤25°C)保存,避光,密封防潮 |
| 溶解性参考 | 可溶于DMSO、DMF、甲醇 |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 36.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份(估) | 1993年 |
| 含氮原子数 | 13 |
| 含硫原子数 | 2 |